| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/07/2023 | 53.1% | Raymond James | $20 → $22 | Maintains | Strong Buy |
| 07/07/2023 | 39.18% | Raymond James | $21 → $20 | Maintains | Strong Buy |
| 06/30/2023 | 39.18% | Citigroup | → $20 | Reiterates | Buy → Buy |
| 04/14/2023 | 46.14% | Raymond James | $19 → $21 | Maintains | Strong Buy |
| 04/12/2023 | 25.26% | Stifel | $22 → $18 | Maintains | Buy |
| 03/27/2023 | 32.22% | Raymond James | $23 → $19 | Maintains | Strong Buy |
| 03/07/2023 | 46.14% | Keybanc | → $21 | Upgrades | Sector Weight → Overweight |
| 01/26/2023 | 60.06% | Raymond James | $26 → $23 | Maintains | Strong Buy |
| 09/20/2022 | — | Keybanc | Initiates Coverage On | → Sector Weight | |
| 08/25/2022 | 67.01% | Citigroup | → $24 | Initiates Coverage On | → Buy |
| 07/26/2022 | 80.93% | Raymond James | $25 → $26 | Maintains | Strong Buy |
| 05/02/2022 | 46.14% | Wells Fargo | $19 → $21 | Maintains | Overweight |
| 04/25/2022 | 73.97% | Raymond James | $22 → $25 | Maintains | Strong Buy |
| 04/14/2022 | 53.1% | Stephens & Co. | → $22 | Initiates Coverage On | → Overweight |
| 04/11/2022 | 25.26% | Keybanc | $17 → $18 | Maintains | Overweight |
| 03/28/2022 | 53.1% | Raymond James | $21 → $22 | Maintains | Strong Buy |
| 01/25/2022 | 46.14% | Raymond James | $22 → $21 | Maintains | Strong Buy |
| 01/21/2022 | 18.3% | Keybanc | $16 → $17 | Maintains | Overweight |
| 11/30/2021 | 25.26% | Wells Fargo | $15 → $18 | Upgrades | Equal-Weight → Overweight |
| 10/26/2021 | 53.1% | Raymond James | $20 → $22 | Maintains | Strong Buy |
| 10/20/2021 | 11.34% | Keybanc | $14 → $16 | Maintains | Overweight |
| 09/14/2021 | 39.18% | Raymond James | $18 → $20 | Maintains | Strong Buy |
| 07/27/2021 | 25.26% | Raymond James | $17 → $18 | Maintains | Strong Buy |
| 06/16/2021 | -2.57% | Keybanc | $13 → $14 | Maintains | Overweight |
| 05/14/2021 | -9.53% | Keybanc | $12 → $13 | Maintains | Overweight |
| 05/10/2021 | 18.3% | Raymond James | $14 → $17 | Maintains | Strong Buy |
| 03/18/2021 | 4.38% | Wells Fargo | → $15 | Downgrades | Overweight → Equal-Weight |
| 03/04/2021 | -2.57% | Raymond James | $13 → $14 | Maintains | Strong Buy |
| 12/08/2020 | -16.49% | Raymond James | $9 → $12 | Maintains | Strong Buy |
| 11/06/2020 | -30.41% | Credit Suisse | $12 → $10 | Maintains | Outperform |
| 11/06/2020 | -2.57% | TD Securities | $14.5 → $14 | Maintains | Buy |
| 07/20/2020 | -30.41% | Raymond James | → $10 | Initiates Coverage On | → Strong Buy |
| 07/07/2020 | 28.74% | TD Securities | → $18.5 | Initiates Coverage On | → Buy |
| 05/11/2020 | -37.37% | SunTrust Robinson Humphrey | $10 → $9 | Maintains | Hold |
| 04/22/2020 | -51.29% | Imperial Capital | $15 → $7 | Maintains | Outperform |
| 03/30/2020 | -23.45% | Keybanc | $14 → $11 | Maintains | Overweight |
| 03/19/2020 | — | Credit Suisse | Assumes | → Outperform | |
| 02/28/2020 | 4.38% | Imperial Capital | $19 → $15 | Maintains | Outperform |
| 01/22/2020 | — | Keybanc | Initiates Coverage On | → Overweight | |
| 01/15/2020 | 32.22% | Imperial Capital | $18 → $19 | Maintains | Outperform |
| 01/14/2020 | 39.18% | Raymond James | $19 → $20 | Maintains | Strong Buy |
| 01/09/2020 | 46.14% | Stifel | → $21 | Reinstates | → Buy |
| 12/19/2019 | 53.1% | UBS | $20 → $22 | Maintains | Buy |
| 10/15/2019 | 32.22% | Wells Fargo | $20 → $19 | Maintains | Outperform |
| 10/04/2019 | — | Wells Fargo | Initiates Coverage On | → Outperform | |
| 05/29/2019 | 25.26% | Stifel | $19 → $18 | Downgrades | Buy → Hold |
| 05/17/2019 | — | UBS | Initiates Coverage On | → Buy | |
| 05/13/2019 | 39.18% | Credit Suisse | → $20 | Upgrades | Neutral → Outperform |
| 05/10/2019 | 32.22% | Stifel | → $19 | Upgrades | Hold → Buy |
| 04/12/2019 | 53.1% | Stephens & Co. | → $22 | Initiates Coverage On | → Overweight |
| 12/07/2018 | 46.14% | Credit Suisse | → $21 | Initiates Coverage On | → Neutral |
| 11/09/2018 | 32.22% | Stifel | → $19 | Downgrades | Buy → Hold |
| 08/16/2018 | 108.77% | Raymond James | $29 → $30 | Maintains | Strong Buy |
What is the target price for Kimbell Royalty Partners (KRP)?
The latest price target for Kimbell Royalty Partners (NYSE: KRP) was reported by Raymond James on August 7, 2023. The analyst firm set a price target for $22.00 expecting KRP to rise to within 12 months (a possible 53.10% upside). 10 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Kimbell Royalty Partners (KRP)?
The latest analyst rating for Kimbell Royalty Partners (NYSE: KRP) was provided by Raymond James, and Kimbell Royalty Partners maintained their strong buy rating.
When is the next analyst rating going to be posted or updated for Kimbell Royalty Partners (KRP)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Kimbell Royalty Partners, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Kimbell Royalty Partners was filed on August 7, 2023 so you should expect the next rating to be made available sometime around August 7, 2024.
Is the Analyst Rating Kimbell Royalty Partners (KRP) correct?
While ratings are subjective and will change, the latest Kimbell Royalty Partners (KRP) rating was a maintained with a price target of $20.00 to $22.00. The current price Kimbell Royalty Partners (KRP) is trading at is $14.37, which is out of the analyst's predicted range.